Lucid Diagnostics Inc. Basic Shares Outstanding (Weighted Average)
Lucid Diagnostics Inc. (LUCD) reported Basic Shares Outstanding (Weighted Average) of 183.12 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- Lucid Diagnostics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 183.12M shares, a 84.99% increase year-over-year.
- Lucid Diagnostics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 140.10M shares, a 103.64% increase year-over-year.
- Lucid Diagnostics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 131.39M shares, a 124.85% increase year-over-year.
- Lucid Diagnostics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 108.18M shares, a 114.75% increase year-over-year.
- Lucid Diagnostics Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 101.95M shares, a 101.81% increase from fiscal 2024.
- Lucid Diagnostics Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 50.52M shares, a 20.98% increase from fiscal 2023.
- Lucid Diagnostics Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 41.76M shares, a 15.44% increase from fiscal 2022.
- Lucid Diagnostics Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 36.17M shares, a 94.44% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 183.12M shares 10-Q · filed 2026-08-12 | 161.73M shares 10-Q · filed 2026-08-12 | 151.54M shares derived: average of 3 quarters · filed 2026-08-12 | 140.70M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 140.10M shares 10-Q · filed 2026-05-13 | 135.74M shares derived: average of 2 quarters · filed 2026-05-13 | 126.56M shares derived: average of 3 quarters · filed 2026-05-13 | 119.66M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | 131.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 119.78M shares derived: average of 2 quarters · filed 2026-03-25 | 112.85M shares derived: average of 3 quarters · filed 2026-08-12 | 101.95M shares 10-K · filed 2026-03-25 |
| 2025-09-30 | 108.18M shares 10-Q · filed 2025-11-12 | 103.58M shares derived: average of 2 quarters · filed 2026-08-12 | 92.13M shares 10-Q · filed 2025-11-12 | 83.60M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | 98.99M shares 10-Q · filed 2026-08-12 | 83.98M shares 10-Q · filed 2026-08-12 | 75.41M shares derived: average of 3 quarters · filed 2026-08-12 | 69.15M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | 68.80M shares 10-Q · filed 2026-05-13 | 63.62M shares derived: average of 2 quarters · filed 2026-05-13 | 59.20M shares derived: average of 3 quarters · filed 2026-05-13 | 56.45M shares derived: average of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | 58.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 54.40M shares derived: average of 2 quarters · filed 2026-03-25 | 52.34M shares derived: average of 3 quarters · filed 2026-03-25 | 50.52M shares 10-K · filed 2026-03-25 |
| 2024-09-30 | 50.37M shares 10-Q · filed 2025-11-12 | 49.29M shares derived: average of 2 quarters · filed 2025-11-12 | 47.88M shares 10-Q · filed 2025-11-12 | 46.49M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 48.21M shares 10-Q · filed 2025-08-12 | 46.61M shares 10-Q · filed 2025-08-12 | 45.19M shares derived: average of 3 quarters · filed 2025-08-12 | 44.36M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 45.01M shares 10-Q · filed 2025-05-13 | 43.68M shares derived: average of 2 quarters · filed 2025-05-13 | 43.07M shares derived: average of 3 quarters · filed 2025-05-13 | 42.76M shares derived: average of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | 42.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 42.11M shares derived: average of 2 quarters · filed 2025-03-24 | 42.01M shares derived: average of 3 quarters · filed 2025-03-24 | 41.76M shares 10-K · filed 2025-03-24 |
| 2023-09-30 | 41.86M shares 10-Q · filed 2024-11-12 | 41.85M shares derived: average of 2 quarters · filed 2024-11-12 | 41.56M shares 10-Q · filed 2024-11-12 | 40.51M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 41.83M shares 10-Q · filed 2024-08-12 | 41.40M shares 10-Q · filed 2024-08-12 | 40.06M shares derived: average of 3 quarters · filed 2024-08-12 | 39.15M shares derived: average of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | 40.97M shares 10-Q · filed 2024-05-13 | 39.18M shares derived: average of 2 quarters · filed 2024-05-13 | 38.25M shares derived: average of 3 quarters · filed 2024-05-13 | 37.63M shares derived: average of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | 37.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | 36.90M shares derived: average of 2 quarters · filed 2024-03-25 | 36.52M shares derived: average of 3 quarters · filed 2024-03-25 | 36.17M shares 10-K · filed 2024-03-25 |
| 2022-09-30 | 36.41M shares 10-Q · filed 2023-11-13 | 36.08M shares derived: average of 2 quarters · filed 2023-11-13 | 35.77M shares 10-Q · filed 2023-11-13 | 34.84M shares derived: average of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | 35.76M shares 10-Q · filed 2023-08-14 | 35.44M shares 10-Q · filed 2023-08-14 | 34.32M shares derived: average of 3 quarters · filed 2023-08-14 | 29.27M shares derived: average of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | 35.12M shares 10-Q · filed 2023-05-15 | 33.60M shares derived: average of 2 quarters · filed 2023-05-15 | 27.10M shares derived: average of 3 quarters · filed 2023-05-15 | 23.86M shares derived: average of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | 32.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | 23.09M shares derived: average of 2 quarters · filed 2023-03-14 | 20.10M shares derived: average of 3 quarters · filed 2023-03-14 | 18.60M shares 10-K · filed 2023-03-14 |
| 2021-09-30 | 14.11M shares 10-Q · filed 2022-11-14 | 14.11M shares derived: average of 2 quarters · filed 2022-11-14 | 14.11M shares 10-Q · filed 2022-11-14 | |
| 2021-06-30 | 14.11M shares 10-Q · filed 2022-08-15 | 14.11M shares 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | 14.11M shares 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |